Numerous recent studies have established that the rs738409 C>G polymorphism encoding for the PNPLA3 I148M variation affects hepatic TG content and is more prevalent among NAFLD patients than healthy controls [39], [40], [72]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.